Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-775-5 | CAS number: 110-52-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from experimental report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- To evaluate the mutagenic potential of test chemical in Salmonella typhimurium strain TA 1535, TA 100, TA 1537, TA 98 by Ames test.
- GLP compliance:
- not specified
- Type of assay:
- bacterial forward mutation assay
Test material
- Reference substance name:
- 1,4-dibromobutane
- EC Number:
- 203-775-5
- EC Name:
- 1,4-dibromobutane
- Cas Number:
- 110-52-1
- Molecular formula:
- C4H8Br2
- IUPAC Name:
- 1,4-dibromobutane
- Test material form:
- liquid
- Details on test material:
- IUPAC name:1,4-dibromobutane
Mol. formula: C4H8Br2
Molecular Weight: 215.915
Smiles: C(CCBr)CBr
InChI: 1S/C4H8Br2/c5-3-1-2-4-6/h1-4H2
Constituent 1
Method
- Target gene:
- Histidine
Species / strain
- Species / strain / cell type:
- S. typhimurium, other: TA 1535, TA 100, TA 1537, TA 98
- Details on mammalian cell type (if applicable):
- Not applicable.
- Additional strain / cell type characteristics:
- other: All strains show a considerably reduced hydrophilic polysaccharide layer (rfa), which leads to an increase in permeability to lipophilic substances.
- Cytokinesis block (if used):
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix was prepared from Sprague-Dawley rats livers induced with Aroclor 1254.
- Test concentrations with justification for top dose:
- 1st Experiment
Strains: TA 1535. TA 100. TA 1537, TA 98
Dose.: 0, 20, 100, 500. 2500 and 5000 µg/plate
2nd Experiment
Strains: TA 100, TA 98
Domes: 0, 20. 100, 500 and 1000 µg/plate
3rd Experiment
Strain: TA 100
Doses: 0, 50, 100, 500, 1000 and 2500 µg/plate
4th Experiment
Strains: TA 1535, JA 1537
Doses: 0, 20, 100, 500, 1000 and 1500 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: Complete solubility of the test substance in DMSO.
Controls
- Untreated negative controls:
- yes
- Remarks:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: + S-9 mix 10 µg 2-aminoanthracene for the strains TA 100, TA 98, TA 1537 and TA 1535 - S-9 mix 5µg N-methyl-N-nitro-Nnitroso;TA 100 and TA 1535 10 µg 4 -nitro-o-phenylenediamine ;strain TA 98 100 µg 9-aminoacridine chloride monohydrate ; TA 1537.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Standard Plate method
- Cell density at seeding (if applicable): >108 bacteria/ml
DURATION
- Preincubation period: 16 hours
- Exposure duration:2days
DETERMINATION OF CYTOTOXICITY
- Method: A bacteriotoxic effectOTHER EXAMINATIONS: - Evaluation criteria:
- A substance to be characterized as positive in the Ames test has to fulfill the following requirements:
- doubling of the spontaneous mutation rate
- dose-response relationship
- reproducibility of the results. - Statistics:
- Yes ,,Mean ±standard deviation was observed.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium, other: TA 1535, TA 100, TA 1537 and TA 98.
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Positive controls validity:
- other: As though the test substace was used as a positive control
- Additional information on results:
- No mutagenic effect were observed in the salmonella typhimurium strain TA 100 used in expriment number three , when exposed to test substance.
- Remarks on result:
- other: No mutagenic effect were observed.
Any other information on results incl. tables
TABLE 1
STRAIN: TA 1535
AMES TEST WITH: 86/221
METHOD: STANDARD PLATE TEST
DOSE MCG/PL |
REVERTANTS/PLATES |
TITER DIL |
QUOTIENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
EXP-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
15 18 21 |
18 |
3 |
21 17 19 |
19
|
2 |
45 41 3 |
1.0 |
1.0 |
20 |
18 16 14 |
16 |
2 |
21 21 26 |
23 |
3 |
|
0.9 |
1.2 |
100 |
18 20 14 |
17 |
3 |
22 22 24 |
23 |
1 |
|
1.0 |
1.2 |
500 |
20 24 21 |
22 |
2 |
28 28 24 |
27 |
2 |
|
1.2 |
1.4 |
2500 |
B B B |
- |
- |
13B 12B 8B |
11 |
3 |
0 0 0 |
- |
0.6 |
5000 |
B B B |
- |
- |
B B B |
- |
- |
0 0 0 |
- |
- |
POSITIVE CONTROL 2-AA 10 |
|
|
|
320 265 242 |
276 |
40 |
|
|
14.5 |
POSITIVE CONTROL MNNG 5 |
1960 2350 2300 |
2203 |
212 |
|
|
|
|
122.4 |
|
* : S-9 FRACTION/COFACTORS = 3: 7 EXP :EXP. TO 10
B: REDUCED his BACKGROUND
TABLE 2
STRAIN: TA 100
AMES TEST WITH: 86/221
METHOD: STANDARD PLATE TEST
DOSE MCG/PL |
REVERTANTS/PLATES |
TITER DIL |
QUOTIENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
EXP-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
94 109 117 |
107 |
12 |
110 104 107 |
107 |
3 |
15 28 11 |
1.0 |
1.0 |
20 |
113 119 111 |
114 |
4 |
102 118 125 |
115 |
12 |
|
1.1 |
1.1 |
100 |
116 117 111 |
112 |
7 |
119 125 113 |
119 |
6 |
|
1.1 |
1.1 |
500 |
113 124 146 |
128 |
17 |
137 139 138 |
138 |
1 |
|
1.2 |
1.3 |
2500 |
B B B |
- |
- |
74B 73B 80B |
76 |
4 |
0 0 0 |
- |
0.7 |
5000 |
B B B |
- |
- |
B B B |
- |
- |
0 0 0 |
- |
- |
POSITIVE CONTROL 2-AA 10 |
|
|
|
1780 1860 1910 |
1850 |
66 |
|
|
17.3 |
POSITIVE CONTROL MNNG 5 |
1740 1930 1850 |
1840 |
95 |
|
|
|
|
17.3 |
|
* : S-9 FRACTION/COFACTORS = 3: 7 EXP :EXP. TO 10
B: REDUCED his BACKGROUND
TABLE 3
STRAIN: TA 1537
AMES TEST WITH: 86/221
METHOD: STANDARD PLATE TEST
DOSE MCG/PL |
REVERTANTS/PLATES |
TITER DIL |
QUOTIENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
EXP-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
13 13 10 |
12 |
2 |
8 10 10 |
9 |
1 |
16 13 11 |
1.0 |
1.0 |
20 |
9 13 8 |
10 |
3 |
15 11 8 |
11 |
4 |
|
0.8 |
1.2 |
100 |
11 10 11 |
11 |
1 |
8 10 8 |
9 |
1 |
|
0.9 |
0.9 |
500 |
16 9 11 |
12 |
4 |
9 9 16 |
11 |
4 |
|
1.0 |
1.2 |
2500 |
B B B |
- |
- |
5B 8B 9B |
7 |
2 |
0 0 0 |
- |
0.8 |
5000 |
B B B |
- |
- |
B B B |
- |
- |
0 0 0 |
- |
- |
POSITIVE CONTROL 2-AA 10 |
|
|
|
199 194 195 |
196 |
3 |
|
|
21.0 |
POSITIVE CONTROL MNNG 5 |
744 661 833 |
746 |
86 |
|
|
|
|
62.2 |
|
* : S-9 FRACTION/COFACTORS = 3: 7 EXP :EXP. TO 10
B: REDUCED his BACKGROUND
TABLE 4
STRAIN: TA 98
AMES TEST WITH: 86/221
METHOD: STANDARD PLATE TEST
DOSE MCG/PL |
REVERTANTS/PLATES |
TITER DIL |
QUOTIENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
EXP-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
22 21 21 |
21 |
1 |
39 32 31 |
34 |
4 |
62 53 57 |
1.0 |
1.0 |
20 |
21 29 22 |
24 |
4 |
31 34 32 |
32 |
2 |
|
1.1 |
1.0 |
100 |
21 21 - |
21 |
0 |
40 32 29 |
34 |
6 |
|
1.0 |
1.0 |
500 |
20 24 23 |
22 |
2 |
35 30 28 |
31 |
4 |
|
1.0 |
0.9 |
2500 |
B B B |
- |
- |
17B 23B 17B |
19 |
3 |
0 0 0 |
- |
0.6 |
5000 |
B B B |
- |
- |
B B B |
- |
- |
0 0 0 |
- |
- |
POSITIVE CONTROL 2-AA 10 |
|
|
|
1992 1800 2000 |
1907 |
101 |
|
|
56.1 |
POSITIVE CONTROL MNNG 5 |
781 839 899 |
840 |
59 |
|
|
|
|
39.4 |
|
* : S-9 FRACTION/COFACTORS = 3: 7 EXP :EXP. TO 10
B: REDUCED his BACKGROUND
Table – 5
AMES TEST WITH 86/221
METHOD: STANDARD PLATE TEST STRAIN: TA 100
DOSE MCG/ PL |
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
116 |
114 |
10 |
105 |
103 |
8 |
1.0 |
1.0 |
103 |
|
|
94 |
|
|
|
|
|
123 |
|
|
109 |
|
|
|
|
|
20 |
99 |
102 |
13 |
115 |
110 |
8 |
0.9 |
1.1 |
91 |
|
|
101 |
|
|
|
|
|
117 |
|
|
113 |
|
|
|
|
|
100 |
93 |
103 |
10 |
97 |
104 |
8 |
0.9 |
1.0 |
112 |
|
|
104 |
|
|
|
|
|
103 |
|
|
112 |
|
|
|
|
|
500 |
109 |
111 |
10 |
112 |
106 |
6 |
1.0 |
1.0 |
102 |
|
|
103 |
|
|
|
|
|
121 |
|
|
102 |
|
|
|
|
|
1000 |
93 |
98 |
9 |
141 |
129 |
10 |
0.9 |
1.3 |
92 |
|
|
123 |
|
|
|
|
|
108 |
|
|
124 |
|
|
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
2100 |
2033 |
76 |
|
19.8 |
|
|
|
2050 |
|
|
|
|
|
|
|
|
1950 |
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
1670 |
1703 |
42 |
|
|
|
14.9 |
|
1750 |
|
|
|
|
|
|
|
|
1690 |
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
* : S9 FRACTION/COFACTORS = 3. 7
Table – 6
AMES TEST WITH 86/33
METHOD: STANDARD PLATE TEST STRAIN: TA 100
DOSE MCG/ PL |
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
116 |
114 |
10 |
105 |
103 |
8 |
1.0 |
1.0 |
103 |
|
|
94 |
|
|
|
|
|
123 |
|
|
109 |
|
|
|
|
|
20 |
122 |
116 |
6 |
117 |
113 |
6 |
1.0 |
1.1 |
113 |
|
|
- |
|
|
|
|
|
112 |
|
|
108 |
|
|
|
|
|
100 |
96 |
110 |
21 |
125 |
132 |
8 |
1.0 |
1.3 |
100 |
|
|
140 |
|
|
|
|
|
134 |
|
|
132 |
|
|
|
|
|
500 |
127 |
128 |
17 |
137 |
152 |
17 |
1.1 |
1.5 |
112 |
|
|
148 |
|
|
|
|
|
145 |
|
|
171 |
|
|
|
|
|
1000 |
149 |
145 |
7 |
207 |
206 |
2 |
1.3 |
2.0 |
150 |
|
|
206 |
|
|
|
|
|
137 |
|
|
204 |
|
|
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
2100 |
2033 |
76 |
|
19.8 |
|
|
|
2050 |
|
|
|
|
|
|
|
|
1950 |
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
1670 |
1703 |
42 |
|
|
|
14.9 |
|
1750 |
|
|
|
|
|
|
|
|
1690 |
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
* : S9 FRACTION/COFACTORS = 3. 7 - : CONTAMINATION
Table – 7
AMES TEST WITH 86/221
METHOD: STANDARD PLATE TEST STRAIN: TA 98
DOSE MCG/ PL |
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
25 |
23 |
2 |
35 |
34 |
4 |
1.0 |
1.0 |
22 |
|
|
38 |
|
|
|
|
|
21 |
|
|
30 |
|
|
|
|
|
20 |
30 |
25 |
6 |
34 |
32 |
2 |
1.1 |
0.9 |
25 |
|
|
32 |
|
|
|
|
|
19 |
|
|
31 |
|
|
|
|
|
100 |
24 |
20 |
4 |
40 |
38 |
3 |
0.7 |
1.1 |
19 |
|
|
36 |
|
|
|
|
|
17 |
|
|
- |
|
|
|
|
|
500 |
17 |
18 |
2 |
29 |
29 |
2 |
0.8 |
0.8 |
20 |
|
|
30 |
|
|
|
|
|
17 |
|
|
27 |
|
|
|
|
|
1000 |
12 |
10 |
3 |
33 |
30 |
3 |
0.5 |
0.9 |
7 |
|
|
30 |
|
|
|
|
|
12 |
|
|
27 |
|
|
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
1433 |
1420 |
26 |
|
41.4 |
|
|
|
1440 |
|
|
|
|
|
|
|
|
1390 |
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
1060 |
1150 |
95 |
|
|
|
50.7 |
|
1140 |
|
|
|
|
|
|
|
|
1250 |
|
|
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
* : S9 FRACTION/COFACTORS = 3. 7 - : CONTAMINATION
Table – 7
AMES TEST WITH 86/221
METHOD: STANDARD PLATE TEST STRAIN: TA 100
DOSE MCG/ PL |
REVERTANTS / PLATE |
TITER DIL |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
EXP-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
117 |
119 |
8 |
110 |
108 |
3 |
14 |
1.0 |
1.0 |
128 |
|
|
104 |
|
|
15 |
|
|
|
112 |
|
|
109 |
|
|
18 |
|
|
|
50 |
91 |
105 |
16 |
121 |
113 |
7 |
|
0.9 |
1.0 |
122 |
|
|
109 |
|
|
|
|
|
|
101 |
|
|
108 |
|
|
|
|
|
|
100 |
123 |
131 |
7 |
103 |
124 |
26 |
|
1.1 |
1.1 |
132 |
|
|
115 |
|
|
|
|
|
|
137 |
|
|
153 |
|
|
|
|
|
|
500 |
113 |
126 |
14 |
108 |
129 |
18 |
|
1.1 |
1.2 |
124 |
|
|
140 |
|
|
|
|
|
|
140 |
|
|
138 |
|
|
|
|
|
|
1000 |
127 |
122 |
8 |
139 |
154 |
13 |
22 |
1.0 |
1.4 |
113 |
|
|
162 |
|
|
31 |
|
|
|
127 |
|
|
162 |
|
|
17 |
|
|
|
5000 |
B |
- |
- |
77 |
74 |
9 |
21 |
- |
0.7 |
B |
|
|
81 |
|
|
16 |
|
|
|
B |
|
|
63 |
|
|
11 |
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
1660 |
1630 |
79 |
|
|
15.1 |
|
|
|
1690 |
|
|
|
|
|
|
|
|
|
1540 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
2150 |
2015 |
191 |
|
|
|
|
16.9 |
|
1880 |
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
*: S59 FRACTION/COFACTORS = 3.7 EXP : EXP. T0 10
-: CONTAMINATION B: REDUCED his- BACKOROUND
Table – 9
AMES TEST WITH 87/33
METHOD: STANDARD PLATE TEST STRAIN: TA 100
DOSE MCG/ PL |
|
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
TITER DIL Exp-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
117 |
119 |
8 |
110 |
108 |
3 |
14 |
1.0 |
1.0 |
128 |
|
|
104 |
|
|
15 |
|
|
|
112 |
|
|
109 |
|
|
18 |
|
|
|
50 |
127 |
119 |
7 |
120 |
119 |
8 |
|
1.0 |
|
115 |
|
|
126 |
|
|
|
|
|
|
114 |
|
|
110 |
|
|
|
|
|
|
100 |
116 |
113 |
3 |
136 |
132 |
5 |
|
0.9 |
1.2 |
110 |
|
|
127 |
|
|
|
|
|
|
113 |
|
|
133 |
|
|
|
|
|
|
500 |
135 |
141 |
9 |
132 |
156 |
26 |
|
1.2 |
1.4 |
152 |
|
|
152 |
|
|
|
|
|
|
137 |
|
|
183 |
|
|
|
|
|
|
1000 |
182 |
173 |
18 |
157 |
170 |
19 |
33 |
1.5 |
1.6 |
153 |
|
|
192 |
|
|
31 |
|
|
|
137 |
|
|
161 |
|
|
34 |
|
|
|
2500 |
211 |
210 |
16 |
235 |
250 |
13 |
26 |
1.8 |
2.3 |
225 |
|
|
253 |
|
|
32 |
|
|
|
193 |
|
|
261 |
|
|
31 |
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
1660 |
1630 |
79 |
|
|
15.1 |
|
|
|
1690 |
|
|
|
|
|
|
|
|
|
1540 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
2150 |
2015 |
191 |
|
|
|
|
16.9 |
|
1880 |
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
Table – 10
AMES TEST WITH 86/221
METHOD: STANDARD PLATE TEST STRAIN: TA1535
DOSE MCG/ PL |
|
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
TITER DIL Exp-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
20 |
19 |
3 |
23 |
20 |
3 |
49 |
1.0 |
1.0 |
16 |
|
|
17 |
|
|
44 |
|
|
|
21 |
|
|
19 |
|
|
51 |
|
|
|
20 |
21 |
23 |
2 |
17 |
17 |
2 |
|
1.2 |
0.8 |
24 |
|
|
15 |
|
|
|
|
|
|
23 |
|
|
18 |
|
|
|
|
|
|
100 |
20 |
20 |
2 |
19 |
17 |
2 |
|
1.1 |
0.8 |
22 |
|
|
16 |
|
|
|
|
|
|
18 |
|
|
15 |
|
|
|
|
|
|
500 |
18 |
19 |
3 |
19 |
20 |
3 |
|
1.0 |
1.0 |
17 |
|
|
18 |
|
|
|
|
|
|
23 |
|
|
24 |
|
|
|
|
|
|
1000 |
22 |
20 |
3 |
18 |
18 |
1 |
55 |
1.1 |
0.9 |
17 |
|
|
17 |
|
|
64 |
|
|
|
21 |
|
|
19 |
|
|
48 |
1.2 |
1.0 |
|
1500 |
24 |
23 |
1 |
20 |
20 |
4 |
56 |
|
|
22 |
|
|
24 |
|
|
57 |
|
|
|
22 |
|
|
17 |
|
|
48 |
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
577 |
481 |
140 |
|
|
24.4 |
|
|
|
545 |
|
|
|
|
|
|
|
|
|
320 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
2050 |
2233 |
176 |
|
|
|
|
117.5 |
|
2250 |
|
|
|
|
|
|
|
|
|
2400 |
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
Table – 11
AMES TEST WITH 86/221
METHOD: STANDARD PLATE TEST STRAIN: TA1535
DOSE MCG/ PL |
|
REVERTANTS / PLATE |
QUOT IENT |
||||||
-S9 |
M |
SD |
+S9* |
M |
SD |
TITER DIL Exp-6 |
-S9 |
+S9* |
|
NEGATIVE CONTROL DMSO |
14 |
14 |
2 |
14 |
15 |
1 |
33 |
1.0 |
1.0 |
12 |
|
|
15 |
|
|
27 |
|
|
|
16 |
|
|
15 |
|
|
27 |
|
|
|
20 |
15 |
15 |
1 |
14 |
14 |
1 |
|
1.1 |
1.0 |
14 |
|
|
13 |
|
|
|
|
|
|
16 |
|
|
15 |
|
|
|
|
|
|
100 |
14 |
13 |
1 |
13 |
13 |
3 |
|
1.0 |
0.9 |
13 |
|
|
16 |
|
|
|
|
|
|
13 |
|
|
10 |
|
|
|
|
|
|
500 |
15 |
13 |
2 |
10 |
13 |
3 |
|
0.9 |
0.9 |
13 |
|
|
15 |
|
|
|
|
|
|
11 |
|
|
13 |
|
|
|
|
|
|
1000 |
10 |
11 |
2 |
12 |
13 |
2 |
32 |
0.8 |
0.9 |
11 |
|
|
12 |
|
|
33 |
|
|
|
13 |
|
|
16 |
|
|
44 |
|
|
|
1500 |
12 |
14 |
2 |
14 |
15 |
2 |
24 |
1.0 |
1.0 |
14 |
|
|
18 |
|
|
32 |
|
|
|
15 |
|
|
14 |
|
|
30 |
|
|
|
POSITIVE CONTROL 2-AA |
|
|
|
203 |
221 |
16 |
|
|
15.1 |
|
|
|
234 |
|
|
|
|
|
|
|
|
|
226 |
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
POSITIVE CONTROL MNNG |
661 |
702 |
109 |
|
|
|
|
50.1 |
|
825 |
|
|
|
|
|
|
|
|
|
619 |
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
Applicant's summary and conclusion
- Conclusions:
- Test chemical was evaluated for its mutagenic potential in Salmonella typhimurium strain TA 1535, TA 100, TA 1537, TA 98 by Ames test. Test chemical, which is known to be positive in the Ames test, was investigated in parallel as a positive control substance (chemical class control) using the strain TA 100. The test result was considered to be negative in the presence and absence of metabolic activation.
- Executive summary:
Test chemical was evaluated for its mutagenic potential in Salmonella typhimurium strain TA 1535, TA 100, TA 1537, TA 98 by Ames test. The test chemical, which is known to be positive in the Ames test, was investigated in parallel as a positive control substance (chemical class control) using the strain TA 100. The test result was considered to be negative in the presence and absence of metabolic activation.Genetic toxicity study was assessed for its possible mutagenic potential. For this purpose AMES test was performed according to guideline OECD 471. The test material was exposed at different concentration in 4 individual experiments. These concentrations are mentioned below :
1st Experiment
Strains: TA 1535. TA 100. TA 1537, TA 98
Doses: 0, 20, 100, 500. 2500 and 5000 µg/plate
2nd Experiment
Strains: TA 100, TA 98
Doses: 0, 20. 100, 500 and 1000 µg/plate
3rd Experiment
Strain: TA 100
Doses: 0, 50, 100, 500, 1000 and 2500 µg/plate
4th Experiment
Strains: TA 1535, JA 1537
Doses: 0, 20, 100, 500, 1000 and 1500 µg/plate
The test material which is known to be positive in the Ames test, was investigated in parallel as a positive control substance (chemical class control) using the strain TA 100. The test material was exposed in the presence and absence of metabolic activation. No mutagenic effects were observed in any of the strain. Thereforetest chemical was considered to be non mutagenic in Salmonella typhimurium strain TA 1535, TA 100, TA 1537, TA 98 by Ames test. Hence the substance cannot be classified as gene mutant in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.